A collaborative analysis of stereotactic lung radiotherapy outcomes for early-stage non-small-cell lung cancer using daily online cone-beam computed tomography image-guided radiotherapy

Journal of Thoracic Oncology

Volumn 7, Issue 9, 2012, Pages 1382-1393

  Grills, Inga Siiner ^a   Hope, Andrew J ^b   Guckenberger, Matthias ^c   Kestin, Larry L ^a   Werner Wasik, Maria ^d   Yan, Di ^a   Sonke, Jan Jakob ^e   Bissonnette, Jean Pierre ^b   Wilbert, Juergen ^c   Xiao, Ying ^d   Belderbos, Jose ^e  

^a OAKLAND UNIVERSITY WILLIAM BEAUMONT SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^e NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Image guided radiotherapy; Non small cell lung cancer; Stereotactic body radiotherapy

Indexed keywords

CARBON MONOXIDE;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; CONE BEAM COMPUTED TOMOGRAPHY; DISTANT METASTASIS; EARLY CANCER; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; IMAGE GUIDED RADIOTHERAPY; LUNG BIOPSY; LUNG CAPACITY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MYOSITIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DERMATITIS; RADIATION DOSE; RADIATION PNEUMONIA; RADIATION RESPONSE; RECURRENT CANCER; RIB FRACTURE; STEREOTACTIC BODY RADIATION THERAPY; SURVIVAL RATE;

EID: 84865689563     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e318260e00d     Document Type: Article

References (46)

1. National Comprehensive Cancer Network Guidelines for Treatment of Cancer by Site: Non-small cell lung cancer, version 2.2012. http://www. nccn.org/professionals/physician-gls/f-guidelines.asp#nscl. Accessed December 4, 2011.
2. Timmerman R, Paulus R, Galvin J, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010;303:1070-1076.
3. Baumann P, Nyman J, Hoyer M, et al. Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol 2009;27:3290-3296.
4. Grutters JP, Kessels AG, Pijls-Johannesma M, De Ruysscher D, Joore MA, Lambin P. Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: a meta-analysis. Radiother Oncol 2010;95:32-40.
5. Palma D, Visser O, Lagerwaard FJ, Belderbos J, Slotman BJ, Senan S. Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small-cell lung cancer: a population-based time-trend analysis. J Clin Oncol 2010;28:5153-5159.
6. Grills IS, Mangona VS, Welsh R, et al. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer. J Clin Oncol 2010;28:928-935.
7. Crabtree TD, Denlinger CE, Meyers BF, et al. Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer. J Thorac Cardiovasc Surg 2010;140:377-386.
8. Sher DJ, Wee JO, Punglia RS. Cost-effectiveness analysis of stereotactic body radiotherapy and radiofrequency ablation for medically inoperable, early-stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2011;81:e767-e774.
9. Lanni TB Jr, Grills IS, Kestin LL, Robertson JM. Stereotactic radiotherapy reduces treatment cost while improving overall survival and local control over standard fractionated radiation therapy for medically inoperable non-small-cell lung cancer. Am J Clin Oncol 2011;34:494-498.
10. Grills IS, Hugo G, Kestin LL, et al. Image-guided radiotherapy via daily online cone-beam CT substantially reduces margin requirements for stereotactic lung radiotherapy. Int J Radiat Oncol Biol Phys 2008;70:1045-1056. (Pubitemid 351296103)
11. Shah C, Grills I, Hugo JD, et al. Variation of tumor baseline position during daily CBCT-guided stereotactic body radiotherapy of lung cancer. Int J Radiat Oncol Biol Phys 2009;75(3):S115-S116.
12. Bissonnette JP, Purdie TG, Higgins JA, Li W, Bezjak A. Cone-beam computed tomographic image guidance for lung cancer radiation therapy. Int J Radiat Oncol Biol Phys 2009;73:927-934.
13. Timmerman R, McGarry R, Papiez L et al. Initial report of a prospective phase II trial of stereotactic body radiation therapy for patients with medically inoperable stage I non-small cell lung cancer. Proc ASTRO 2005 Int J Radiat Oncol Biol Phys 2005;63:S99.
14. McGarry RC, Papiez L, Williams M, Whitford T, Timmerman RD. Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study. Int J Radiat Oncol Biol Phys 2005;63:1010-1015. (Pubitemid 41505277)
15. Onishi H, Shirato H, Nagata Y, et al. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol 2007;2(7 Suppl 3):S94-S100. (Pubitemid 47183602)
16. Wulf J, Baier K, Mueller G, Flentje MP. Dose-response in stereotactic irradiation of lung tumors. Radiother Oncol 2005;77:83-87. (Pubitemid 41503394)
17. Wolthaus JW, Sonke JJ, van Herk M, Damen EM. Reconstruction of a time-averaged midposition CT scan for radiotherapy planning of lung cancer patients using deformable registration. Med Phys 2008;35:3998-4011.
18. Belderbos J, Grills I, Sonke J, et al. A multinational report on methods for delivery of lung stereotactic radiotherapy (SBRT) using online volumetric image-guidance (VIGRT): results from the Synergy Research Group. Int J Radiat Oncol Biol Phys 2009;75(3 Suppl):S159-S160.
19. Fowler JF, Tomé WA, Fenwick JD, Mehta MP. A challenge to traditional radiation oncology. Int J Radiat Oncol Biol Phys 2004;60:1241-1256. (Pubitemid 39440811)
20. Nagata Y, Takayama K, Matsuo Y, et al. Clinical outcomes of a phase I/ II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 2005;63:1427-1431. (Pubitemid 41628038)
21. Uematsu M, Shioda A, Suda A, et al. Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experience. Int J Radiat Oncol Biol Phys 2001;51:666-670.
22. Zimmermann FB, Geinitz H, Schill S, et al. Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer. Lung Cancer 2005;48:107-114. (Pubitemid 40381006)
23. Fakiris AJ, McGarry RC, Yiannoutsos CT, et al. Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study. Int J Radiat Oncol Biol Phys 2009;75:677-682.
24. Fukumoto S, Shirato H, Shimzu S, et al. Small-volume image-guided radiotherapy using hypofractionated, coplanar, and noncoplanar multiple fields for patients with inoperable Stage I nonsmall cell lung carcinomas. Cancer 2002;95:1546-1553.
25. Hof H, Herfarth KK, Münter M, et al. Stereotactic single-dose radiotherapy of stage I non-small-cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 2003;56:335-341. (Pubitemid 36542890)
26. Onimaru R, Fujino M, Yamazaki K, et al. Steep dose-response relationship for stage I non-small-cell lung cancer using hypofractionated high-dose irradiation by real-time tumor-tracking radiotherapy. Int J Radiat Oncol Biol Phys 2008;70:374-381.
27. Dosoretz DE, Katin MJ, Blitzer PH, et al. Radiation therapy in the management of medically inoperable carcinoma of the lung: results and implications for future treatment strategies. Int J Radiat Oncol Biol Phys 1992;24:3-9.
28. Krol AD, Aussems P, Noordijk EM, Hermans J, Leer JW. Local irradiation alone for peripheral stage I lung cancer: could we omit the elective regional nodal irradiation? Int J Radiat Oncol Biol Phys 1996;34: 297-302. (Pubitemid 26031573)
29. Jeremic B, Shibamoto Y, Acimovic L, Milisavljevic S. Hyperfractionated radiotherapy alone for clinical stage I nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys 1997;38:521-525. (Pubitemid 27305012)
30. Hayakawa K, Mitsuhashi N, Saito Y, et al. Limited field irradiation for medically inoperable patients with peripheral stage I non-small cell lung cancer. Lung Cancer 1999;26:137-142. (Pubitemid 30114215)
31. Sibley GS, Jamieson TA, Marks LB, Anscher MS, Prosnitz LR. Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience. Int J Radiat Oncol Biol Phys 1998;40:149-154. (Pubitemid 28027580)
32. Morita K, Fuwa N, Suzuki Y, et al. Radical radiotherapy for medically inoperable non-small cell lung cancer in clinical stage I: a retrospective analysis of 149 patients. Radiother Oncol 1997;42:31-36. (Pubitemid 27078109)
33. Guckenberger M, Krieger T, Richter A, et al. Potential of image-guidance, gating and real-time tracking to improve accuracy in pulmonary stereotactic body radiotherapy. Radiother Oncol 2009;91:288-295.
34. Timmerman R, Papiez L, McGarry R, et al. Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 2003;124:1946-1955. (Pubitemid 37433596)
35. Stephans KL, Djemil T, Reddy CA, et al. A comparison of two stereotactic body radiation fractionation schedules for medically inoperable stage I non-small cell lung cancer: the Cleveland Clinic experience. J Thorac Oncol 2009;4:976-982.
36. Chang JY, Balter PA, Dong L, et al. Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2008;72:967-971.
37. Bradley JD, El Naqa I, Drzymala RE, Trovo M, Jones G, Denning MD. Stereotactic body radiation therapy for early-stage non-small-cell lung cancer: the pattern of failure is distant. Int J Radiat Oncol Biol Phys 2010;77:1146-1150.
38. Chen Y, Guo W, Lu Y, Zou B. Dose-individualized stereotactic body radiotherapy for T1-3N0 non-small cell lung cancer: long-term results and efficacy of adjuvant chemotherapy. Radiother Oncol 2008;88:351-358.
39. Winton T, Livingston R, Johnson D, et al. National Cancer Institute of Canada Clinical Trials Group; National Cancer Institute of the United States Intergroup JBR.10 Trial Investigators. Vinorelbine plus cisplatin observation in resected non-small-cell lung cancer. N Engl J Med 2005;352:2589-2597.
40. Arriagada R, Bergman B, Dunant A, Le Chevalier T, Pignon JP, Vansteenkiste J; International Adjuvant Lung Cancer Trial Collaborative Group. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 2004;350:351-360. (Pubitemid 38101630)
41. Scagliotti GV, Fossati R, Torri V, et al. Adjuvant Lung Project Italy/ European Organisation for Research Treatment of Cancer-Lung Cancer Cooperative Group Investigators. Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell Lung cancer. J Natl Cancer Inst 2003;95:1453-1461.
42. Pignon JP, Tribodet H, Scagliotti GV, et al. LACE Collaborative Group. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. J Clin Oncol 2008;26:3552-3559.
43. Strauss GM, Herndon JE 2nd, Maddaus MA, et al. Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups. J Clin Oncol 2008;26:5043-5051.
44. International randomized study to compare CyberKnife stereotactic radiotherapy with surgical resection in stage I non-small cell lung cancer. Available at http://www.cancer.gov/clinicaltrials/search/view?cdri d=635570&version=HealthProfessional&protocolssearchid=8886817. Accessed March 9, 2011.
45. Trial of either surgery or stereotactic radiotherapy for early stage (IA) lung cancer. Available at http://www.cancer.gov/clinicaltrials/search/view?cdr id=597713&version=HealthProfessional&protocolssearchid=8886817. Accessed March 9, 2011.
46. Welsh R, Grills IS, Deraniyagala R, et al. Lobectomy, wedge resection, or stereotactic radiotherapy (SBRT) for stage I non-small cell lung cancer: which treatment yields the best outcome? Int J Radiat Oncol Biol Phys 2010;78(3):S180